J Matthew Singleton - Net Worth and Insider Trading
J Matthew Singleton Net Worth
The estimated net worth of J Matthew Singleton is at least $391,020 dollars as of 2024-12-28. J Matthew Singleton is the Director of Viking Therapeutics Inc and owns about 9,500 shares of Viking Therapeutics Inc (VKTX) stock worth over $391,020. Details can be seen in J Matthew Singleton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that J Matthew Singleton has not made any transactions after 2024-10-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of J Matthew Singleton
J Matthew Singleton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, J Matthew Singleton owns 1 companies in total, including Viking Therapeutics Inc (VKTX) .
Click here to see the complete history of J Matthew Singleton’s form 4 insider trades.
Insider Ownership Summary of J Matthew Singleton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VKTX | Viking Therapeutics Inc | 2024-10-25 | director |
J Matthew Singleton Latest Holdings Summary
J Matthew Singleton currently owns a total of 1 stock. J Matthew Singleton owns 9,500 shares of Viking Therapeutics Inc (VKTX) as of October 25, 2024, with a value of $391,020.
Latest Holdings of J Matthew Singleton
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VKTX | Viking Therapeutics Inc | 2024-10-25 | 9,500 | 41.16 | 391,020 |
Holding Weightings of J Matthew Singleton
J Matthew Singleton Form 4 Trading Tracker
According to the SEC Form 4 filings, J Matthew Singleton has made a total of 5 transactions in Viking Therapeutics Inc (VKTX) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Viking Therapeutics Inc is the sale of 16,000 shares on October 25, 2024, which brought J Matthew Singleton around $1 Million.
Insider Trading History of J Matthew Singleton
- 1
J Matthew Singleton Trading Performance
GuruFocus tracks the stock performance after each of J Matthew Singleton's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by J Matthew Singleton is 30.83%. GuruFocus also compares J Matthew Singleton's trading performance to market benchmark return within the same time period. The performance of stocks bought by J Matthew Singleton within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how J Matthew Singleton's insider trading performs compared to the benchmark.
Performance of J Matthew Singleton
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -5.01 | | | | | |
| Relative Return to S&P 500(%) | -5.49 | | | | | |
J Matthew Singleton Ownership Network
J Matthew Singleton Owned Company Details
What does Viking Therapeutics Inc do?
Who are the key executives at Viking Therapeutics Inc?
J Matthew Singleton is the director of Viking Therapeutics Inc. Other key executives at Viking Therapeutics Inc include Chief Financial Officer Greg Zante , director & President & CEO Brian Lian , and Chief Operating Officer Marianna Mancini .
Viking Therapeutics Inc (VKTX) Insider Trades Summary
Over the past 18 months, J Matthew Singleton made 5 insider transaction in Viking Therapeutics Inc (VKTX) with a net sale of 68,786. Other recent insider transactions involving Viking Therapeutics Inc (VKTX) include a net sale of 879,938 shares made by Brian Lian , a net sale of 229,579 shares made by Greg Zante , and a net sale of 66,000 shares made by Sarah Kathryn Rouan .
In summary, during the past 3 months, insiders sold 160,687 shares of Viking Therapeutics Inc (VKTX) in total and bought 0 shares, with a net sale of 160,687 shares. During the past 18 months, 1,545,754 shares of Viking Therapeutics Inc (VKTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,545,754 shares.
Viking Therapeutics Inc (VKTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Viking Therapeutics Inc Insider Transactions
J Matthew Singleton Mailing Address
Above is the net worth, insider trading, and ownership report for J Matthew Singleton. You might contact J Matthew Singleton via mailing address: 286 Stanwich Road, Greenwich Ct 06830.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
